ADIFAB/ADIFAB2 Reagents

About FFA Sciences

FFA Sciences has developed a proprietary, patented platform based on fluorescently labeled fatty acid-binding proteins (FABPs), such as ADIFAB and ADIFAB2, to measure unbound free fatty acids in biological fluids in under a minute. While its initial focus is on ophthalmology, where FFAu is implicated in diseases like diabetic retinopathy and dry AMD, the technology has broad applicability in drug discovery, enzymology, and metabolomics profiling. The company generates revenue through the sale of assay kits and reagents, as well as providing contract research services, positioning it as a tools and services company rather than a therapeutic developer.

Therapeutic Areas